Lung cancer development is closely associated with genetic alterations such as epidermal growth factor receptor (EGFR) mutation, anaplastic lymphoma kinase (ALK) rearrangement, and kirsten rats arcomaviral oncogene homolog (KRAS) mutation [2], and its progression and metastasis are also associated with microenvironment changes. Here, ALK is linked to lung cancer.